Search Results - Aarnoutse, Rob, Prof

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials

    Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials by Musisi, Emmanuel, PhD, Wyness, Adam, PhD, Eldirdiri, Sahar, MD, Dombay, Evelin, PhD, Mtafya, Bariki, PhD, Ntinginya, Nyanda E, PhD, Heinrich, Norbert, Prof, Kibiki, Gibson S, Prof, Hoelscher, Michael, PhD, Boeree, Martin, Prof, Aarnoutse, Rob, Prof, Gillespie, Stephen H, Prof, Sabiiti, Wilber, PhD

    Published in The Lancet. Microbe
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

    Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised,... by Heinrich, Norbert, MD PhD, de Jager, Veronique, MBChB, Dreisbach, Julia, DVM, Gross-Demel, Petra, PhD, Schultz, Susanne, MD, Gerbach, Sina, PhD, Kloss, Florian, PhD, Dawson, Rodney, Prof, Narunsky, Kim, MD, Matt, Leoni, MD, Wildner, Leticia, PhD, McHugh, Timothy D, Prof, Fuhr, Uwe, Prof, Aldana, Brian H, MPh, Mouhdad, Chaima, PharmD, Brake, Lindsey te, PhD, Boeree, Martin J, Prof, Aarnoutse, Rob E, Prof, Svensson, Elin M, PhD, Gong, Xue, MSc, P J Phillips, Patrick, PhD, Diacon, Andreas H, MD, Hoelscher, Michael, Prof

    Published in The Lancet. Microbe
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

    Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial by Ruslami, Rovina, PhD, Ganiem, A Rizal, MD, Dian, Sofiati, MD, Apriani, Lika, MSc, Achmad, Tri Hanggono, Prof, van der Ven, Andre J, Prof, Borm, George, Prof, Aarnoutse, Rob E, PhD, van Crevel, Reinout, Dr

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial by Boeree, Martin J, PhD, Heinrich, Norbert, MD, Aarnoutse, Rob, PhD, Diacon, Andreas H, PhD, Dawson, Rodney, PhD, Rehal, Sunita, MSc, Kibiki, Gibson S, Prof, Churchyard, Gavin, Prof, Sanne, Ian, FRCP, Ntinginya, Nyanda E, MD, Minja, Lilian T, MD, Hunt, Robert D, BSc, Charalambous, Salome, PhD, Hanekom, Madeleine, PhD, Semvua, Hadija H, PhD, Mpagama, Stellah G, PhD, Manyama, Christina, MD, Mtafya, Bariki, MSc, Reither, Klaus, MD, Wallis, Robert S, Prof, Venter, Amour, NatDipMicr, Narunsky, Kim, MD, Mekota, Anka, PhD, Henne, Sonja, MSc, Colbers, Angela, PhD, van Balen, Georgette Plemper, PhD, Gillespie, Stephen H, Prof, Phillips, Patrick P J, PhD, Hoelscher, Michael, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: